4.6 Article

Oral Administration and Selective Uptake of Polymeric Nanoparticles in Drosophila Larvae as an in Vivo Model

Journal

ACS BIOMATERIALS SCIENCE & ENGINEERING
Volume 1, Issue 11, Pages 1077-1084

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.5b00163

Keywords

PLGA nanoparticles; chitosan; oral delivery; Drosophila larva; in vivo model

Funding

  1. A*STAR Joint Council Office
  2. Institute of Materials Research and Engineering
  3. Bioinformatics Institute

Ask authors/readers for more resources

In this article, Drosophila larvae are applied as an in vivo model to investigate the transport and uptake of polymeric nanoparticles in the larval digestive tract after oral administration. After feeding the larvae with food containing bare and chitosan-coated Poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles encapsulated with BODIPY, time-lapse imaging of live larvae is used to monitor the movement of fluorescent nanoparticles in the anterior, middle, and posterior midgut of the digestive tract. Also, the dissection of the digestive tract enables the analysis of cellular uptake in the midgut. Bare PLGA nanoparticles travel through the whole midgut smoothly while chitosan-coated PLGA nanoparticles have a long retention time in the posterior midgut. We identify that this retention occurs in the posterior segment of the posterior midgut, and it is termed as the retention segment. During transport in the midgut, chitosan-coated nanoparticles pass through the near-neutral anterior midgut and become highly positively charged when entering into the highly acidic middle midgut. After traveling through the near-neutral anterior segment of the posterior midgut, chitosan-coated nanoparticles have a long retention time of similar to 10 h in the retention segment, indicating that the chitosan coating greatly enhances mucoadhesive ability and promotes cellular uptake in this part of the midgut. The dynamic behavior of orally administered nanoparticles in Drosophila larvae is in agreement with studies in other animal models. A Drosophila larva has the potential to evolve into a low-cost drug screening model through real time imaging, which will accelerate the development of improved nanoparticle formulations for oral drug delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available